Townsquare Capital LLC Cerus Corp Transaction History

Townsquare Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	SELL	$1.25 - $2.35 $23,123 - $43,472	-18,499 Reduced 48.64%	19,537 $42,000
Q3 2023 Nov 15, 2023	SELL	$1.5 - $3.07 $139,249 - $284,997	-92,833 Reduced 70.94%	38,036 $61,000
Q2 2023 Nov 13, 2023	BUY	$1.79 - $2.9 $185,800 - $301,017	103,799 Added 383.45%	130,869 $321,000
Q1 2023 May 11, 2023	SELL	$2.65 - $3.81 $190,020 - $273,199	-71,706 Reduced 72.59%	27,070 $80,000
Q4 2022 Feb 13, 2023	SELL	$3.38 - $4.22 $21,763 - $27,172	-6,439 Reduced 6.12%	98,776 $360,000
Q3 2022 Nov 10, 2022	BUY	$3.43 - $5.83 $23,883 - $40,594	6,963 Added 7.09%	105,215 $379,000
Q2 2022 Aug 08, 2022	BUY	$4.41 - $5.69 $190,432 - $245,705	43,182 Added 78.41%	98,252 $519,000
Q1 2022 Apr 28, 2022	BUY	$4.81 - $6.99 $264,886 - $384,939	55,070 New	55,070 $302,000

156

148M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $317M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Townsquare Capital LLC with notifications on news.